Recently, California’s Office of Health Care Affordability (“OHCA”) made significant development in implementing SB 184’s pre-transaction notice requirements with the publication of its updated draft regulations.
The noteworthy update appears to place certain checks on the extent of transactions that need to adhere to the notice requirement. This modification aims towards streamlining the regulatory framework by focusing chiefly on the most impactful transactions.
The draft regulations would, however, also provide clarification on the procedures adopted by the OHCA for reviewing transactions. This aspect, clear communication of procedural requirements, promotes transparency and is designed to manage expectations related to the review’s duration and complexity.
It’s important to note that these provisions in the draft regulations can potentially undergo additional changes, making it imperative for corporations, professionals, and stakeholders in the healthcare industry to stay abreast of the latest progress. This would ensure that their transactions maintain compliance with the evolving framework, and any potential violations or oversight can be duly avoided.
The latest draft regulations are being critically reviewed by law firms, including Polsinelli, which is known for offering comprehensive legal services to clients in healthcare and other industries. Their scrutiny will presumably help clarify any areas of ambiguity or concern, contributing to the ongoing development of sound regulatory infrastructure for healthcare transactions.